You may also like
Anticoagulation With an Inhibitor of Factors XIa and XIIa During Cardiopulmonary Bypass
Preclinical animal models used in this study showed that Ir-CPI is an effective and safe antithrombotic agent that provides a clinically relevant approach to thrombosis prevention in bypass systems, including highly thrombogenic CPB.
1 min read
Feeding Intolerance and Risk of Poor Outcome in Patients Undergoing Cardiopulmonary Bypass Surgery
Thus, the incidence of FI within seven days of EN after CPB was high, which was associated with a poor prognosis.
1 min read
Heart Rescue: The Role of Mechanical Circulatory Support in the Management of Severe Refractory Cardiogenic Shock
This article will review novel strategies in the management of cardiogenic shock including percutaneous MCS (intra-aortic balloon pump, Impella, TandemHeart, venoarterial extracorporeal membrane oxygenation) and surgically implanted devices (CentriMag) that are used for short-term management
1 min read